Search research articles
Contact Us
Filters
Showing results (151-160 of 251) with videos related to
Page
of 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients
E Van Cutsem, H Prenen, G D'Haens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R K Kelley, C Verslype, A L Cohn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
J M Blazeby, T Conroy, A Bottomley, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
Annals of Surgery
|
November 23, 2000
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy
T Lerut, P Flamen, N Ectors, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2007
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
W De Roock, H Piessevaux, J De Schutter, et al.
British Journal of Cancer
|
November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
S Siena, M Peeters, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2014
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F Ciardiello, D Arnold, P G Casali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study
E Van Cutsem, M Findlay, B Osterwalder, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 251) with videos related to
Sort By:
Page
of 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients
E Van Cutsem, H Prenen, G D'Haens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
R K Kelley, C Verslype, A L Cohn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
J M Blazeby, T Conroy, A Bottomley, et al.
British Journal of Cancer
|
March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study
E Van Cutsem, L Dirix, J-L Van Laethem, et al.
Annals of Surgery
|
November 23, 2000
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy
T Lerut, P Flamen, N Ectors, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2007
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
W De Roock, H Piessevaux, J De Schutter, et al.
British Journal of Cancer
|
November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
S Siena, M Peeters, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2014
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F Ciardiello, D Arnold, P G Casali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study
E Van Cutsem, M Findlay, B Osterwalder, et al.
Page
of 26